The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans - Wikidata - wikimedia - TriplyDB

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

http://www.wikidata.org/entity/Q34347554

about

Possible augmentation of photosensitivity by dietary furanocoumarins in patients with systemic lupus erythematosus.Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function.Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioid-treated human volunteers.Mechanistic approaches to volume of distribution predictions: understanding the processes.

P2860

Q37902374-3859D38A-30E7-4E5A-9DF9-B8276A096A21 Q41597242-71B86C07-D203-477C-A0EA-5C948E4B10DA Q43655377-E3376AAB-9EA0-4192-89B9-F580E6635924 Q44349579-8CEDB872-4BCB-4AF6-9639-615D1840735E Q51919468-07DB176F-2A64-4EA0-A4CB-5A88CA80C9BD

P2860

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

http://www.wikidata.org/entity/Q34347554

description

1995 nî lūn-bûn

@nan

1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@ast

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@en

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@nl

type

label

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@ast

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@en

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@nl

prefLabel

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@ast

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@en

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@nl

P1433

Q34347554-D57E6012-4838-4654-B236-C9D23662AC3E

P1476

Q34347554-9765D59B-8E88-408F-AAB8-BE7D440160E3

P2093

Q34347554-0637CB06-7DC8-4600-9C7C-B1A012A73110

Q34347554-179CE954-CAF3-41BC-8470-6926B5F65034

Q34347554-2735299A-E91B-4F03-A927-60FE8DC5B71E

Q34347554-3C35A599-AC50-49FF-91EC-54AD10075A93

Q34347554-441B26F3-C50B-45B7-94A0-A787317287EF

Q34347554-73BF65D9-0702-467F-8B71-FAA4CBD019AB

Q34347554-8BFA522F-E9BF-4C7C-8E25-E89F8F93786D

Q34347554-D12CAC9E-B3CF-4DEA-9CDB-D5717C1136D2

P2860

Q34347554-275D6A9E-D7AD-4584-9F07-26A4AB78E727

Q34347554-50281AE5-D919-4294-87E5-6432F68BDBD6

Q34347554-6FEB7F26-C5D1-44E0-9DCF-DE54037F6C22

Q34347554-7CEBE6FD-6B94-434C-9EE2-29A6FBA9F60E

Q34347554-7CF65FD2-D3CA-4995-95B9-488EB5FB2AAD

Q34347554-AADFC1A2-D9EE-4A74-9597-2B3563AE06D1

Q34347554-B79904B7-C793-4727-AB85-86D7D48AFB0F

Q34347554-BE218B27-EA0D-4A15-B803-97172DDB2985

Q34347554-F75862BC-4873-4C37-A345-4B73F8439292

P304

Q34347554-B12CEDC1-D1AA-4302-8BDA-33B5684808CB

P31

Q34347554-07AB048F-40F7-4934-A6F0-D6983A4C9814

P356

Q34347554-CF286076-B0E7-4778-97DE-A08C7F503D6E

P407

Q34347554-21E368EB-BFC1-4F2F-9258-0C1D4A79DE88

P433

Q34347554-66551D13-1F61-4F86-85DE-A67BE84B9FE2

P478

Q34347554-D754B1F1-947C-476D-8044-0C134BEF0A97

P577

Q34347554-3C97282A-EDF7-4AFD-A65E-61A11AFB61C1

P5875

Q34347554-A546A1FE-6E8E-4C30-8462-597365089F70

P698

Q34347554-5F331881-D7B8-4AE2-B100-F6088B342D30

P932

Q34347554-B593195D-E39E-4907-81E8-AAA165BAB7F5

P356

J.1365-2125.1995.TB04557.X

P1433

British Journal of Clinical Pharmacology

P1476

The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans

@en

P2093

Barr J

http://www.w3.org/2001/XMLSchema#string

Billard V

http://www.w3.org/2001/XMLSchema#string

Corash L

http://www.w3.org/2001/XMLSchema#string

Gambus PL

http://www.w3.org/2001/XMLSchema#string

Minto CF

http://www.w3.org/2001/XMLSchema#string

Shafer SL

http://www.w3.org/2001/XMLSchema#string

Stickney JL

http://www.w3.org/2001/XMLSchema#string

Tessman JW

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.

Photochemical inactivation of pathogenic bacteria in human platelet concentrates.

'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.

The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.

General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment.

Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.

Pharmacokinetics of 8-methoxypsoralen in the dog.

Binding of 8-methoxypsoralen to human serum proteins and red blood cells.

CLINICAL CALORIMETRY

P304

347-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1995.TB04557.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1995-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14645463

http://www.w3.org/2001/XMLSchema#string

P698

8554937

http://www.w3.org/2001/XMLSchema#string

P932

1365154

http://www.w3.org/2001/XMLSchema#string